Senator Questions Company’s Response To Paid Consultant’s Complaints About Zimmer Durom Cup

In a letter, previously posted on the WSJ website, to Zimmer CEO David Dvorak, Senator Charles Grassley raised questions regarding how the company responds to criticisms concerning joint replacement products, including the Zimmer Durom Cup (also known as the Zimmer Durom Acetabular Cup), by physicians who are paid company consultants. Grassley has a history of seeking legislative transparency and cooperation concerning medical devices.

The Zimmer Durom Cup was introduced in the United States in 2006 as a hip replacement component. Intended to be an improvement, the cup has caused serious problems for many total hip replacement patients, including extreme pain and discomfort, and the need for additional surgeries. As a result, lawsuits have been filed across the country seeking damages – often claiming that that the hip replacement component is defective, and that Zimmer failed to provide adequate warnings or instructions about the proper use and surgical techniques for proper implantation.

Citing a recent New York Times article exposing growing disputes between physicians and orthopedic implant manufacturers, Grassley seeks answers about how problems are investigated. Many of these devices are approved by the Food and Drug Administration for sale without testing.

Unfortunately, it is often innocent patients who suffer the costs when these faulty medical devices remain on the market. For more information, or if you or a loved how has experienced discomfort or other hip replacement problems, please contact the attorneys at the Branch Law Firm.